[go: up one dir, main page]

MX2018011082A - Péptido o aminoácido n-lipoico, derivados y sus usos. - Google Patents

Péptido o aminoácido n-lipoico, derivados y sus usos.

Info

Publication number
MX2018011082A
MX2018011082A MX2018011082A MX2018011082A MX2018011082A MX 2018011082 A MX2018011082 A MX 2018011082A MX 2018011082 A MX2018011082 A MX 2018011082A MX 2018011082 A MX2018011082 A MX 2018011082A MX 2018011082 A MX2018011082 A MX 2018011082A
Authority
MX
Mexico
Prior art keywords
lipoic
derivatives
amino acid
peptide
compositions
Prior art date
Application number
MX2018011082A
Other languages
English (en)
Inventor
J Yu Ruey
J Vanscott Eugene
Original Assignee
Neostrata Company Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neostrata Company Inc filed Critical Neostrata Company Inc
Publication of MX2018011082A publication Critical patent/MX2018011082A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • C07K5/06121—Asp- or Asn-amino acid the second amino acid being aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Immunology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen compuestos novedosos de aminoácido N-lipoico, péptidos N-lipoicos y sus derivados. También se describen composiciones y métodos de composiciones que contienen los derivados de los aminoácidos o péptidos, y sus usos, que incluyen el tratamiento y la prevención de afecciones dermatológicas o cosméticas u otros trastornos del sistema cutáneo. También se describen composiciones y métodos para usar las composiciones para aclaramiento de la piel y cosméticos.
MX2018011082A 2016-03-14 2016-03-14 Péptido o aminoácido n-lipoico, derivados y sus usos. MX2018011082A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2016/022289 WO2017160269A1 (en) 2016-03-14 2016-03-14 N-lipoic -amino acid or peptide, derivatives and their uses

Publications (1)

Publication Number Publication Date
MX2018011082A true MX2018011082A (es) 2019-03-28

Family

ID=59850403

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018011082A MX2018011082A (es) 2016-03-14 2016-03-14 Péptido o aminoácido n-lipoico, derivados y sus usos.

Country Status (12)

Country Link
US (1) US11155531B2 (es)
EP (2) EP4018997A1 (es)
JP (1) JP6858837B2 (es)
KR (1) KR102626973B1 (es)
CN (1) CN109152757A (es)
AU (1) AU2016397562B2 (es)
CA (1) CA3017449C (es)
DK (1) DK3429577T3 (es)
ES (1) ES2906178T3 (es)
MX (1) MX2018011082A (es)
RU (1) RU2737377C2 (es)
WO (1) WO2017160269A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12435056B2 (en) * 2016-03-14 2025-10-07 Neostrata Company, Inc. N-lipoic-amino acid or peptide, derivatives and their uses
IL309732A (en) 2021-07-09 2024-02-01 Aligos Therapeutics Inc Antiviral compounds
WO2023043816A1 (en) 2021-09-17 2023-03-23 Aligos Therapeutics, Inc. Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
KR102404228B1 (ko) * 2022-02-18 2022-05-31 주식회사 차메디텍 항산화 효과를 증대시키는 환원된 리포익산-펩타이드 유도체를 포함하는 조성물 및 이의 제조 방법

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63107071A (ja) * 1986-10-23 1988-05-12 Nec Corp 電界効果トランジスタの製造方法
JPH11269170A (ja) 1997-04-02 1999-10-05 Sankyo Co Ltd ジチオラン誘導体
IL123887A0 (en) 1997-04-02 1998-10-30 Sankyo Co Dithiolan derivatives their use and pharmaceutical compositions containing the same
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
ES2259034T3 (es) * 2000-06-06 2006-09-16 Basf Aktiengesellschaft Uso de un enantiomero del acido lipoico en cosmeticos y dermatologicos.
JP4259813B2 (ja) * 2001-05-29 2009-04-30 千寿製薬株式会社 α−リポイルアミノ酸の安定化法および安定化されたα−リポイルアミノ酸を含有する水性液剤
JP2003286168A (ja) * 2002-03-28 2003-10-07 Senju Pharmaceut Co Ltd α−リポイルアミノ酸を含有する皮膚外用剤
WO2003084532A1 (en) * 2002-04-03 2003-10-16 Avery Mitchell A Lipoic acid analogs useful as provitamins and antioxidants
FR2870244B1 (fr) * 2004-05-11 2011-01-07 Centre Nat Rech Scient Conjugues dipeptidiques antagonistes de l'alpha-msh
FR2870242B1 (fr) * 2004-05-11 2010-08-20 Inst Europeen Biologie Cellulaire Peptides ou conjugues peptidiques derives de la msh et leur utilisation dans le traitement cosmetique de la canitie.
JP2006022066A (ja) 2004-07-09 2006-01-26 Shiseido Co Ltd 重合抑制剤および即時型黒化防止用皮膚外用剤
US7776915B2 (en) 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
GB0605295D0 (en) * 2006-03-16 2006-04-26 Proximagen Ltd Amino and derivatives
WO2009003284A1 (en) * 2007-06-29 2009-01-08 Innovactiv Inc. Novel peptides, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same
WO2009020317A2 (en) * 2007-08-06 2009-02-12 Biogenics, Inc. Stabilized antioxidant particles, composition comprising the same and method for preparing the same
BRPI0914457A2 (pt) * 2008-10-17 2015-10-27 Invasc Therapeutics Inc composto, composição farmacêutica, método para reduzir angiotensão convertendo atividade de enzima, método para tratar uma perturbação relacionada com o sistema de renina-angiotensina aldosterona, método para tratar derrame cerebral
US8946451B2 (en) * 2009-10-05 2015-02-03 Catabasis Pharmaceuticals, Inc. Lipoic acid acylated salicylate derivatives and their uses
JP2011195516A (ja) * 2010-03-19 2011-10-06 Oita Univ 制がん剤
BR112013012057B1 (pt) * 2010-11-18 2021-11-09 Ischemix Llc Compostos de lipoil e seu uso para o tratamento de lesões isquêmicas
DK3777876T3 (da) * 2011-10-28 2023-10-30 Neostrata Company Inc N-acyldipeptid-derivater og anvendelser deraf
US20150329519A1 (en) * 2014-05-14 2015-11-19 Ischemix, LLC Formulations Comprising Lipoyl Compounds
JP6271346B2 (ja) 2014-06-12 2018-01-31 アトムメディカル株式会社 ガス類供給用マスク装置

Also Published As

Publication number Publication date
CA3017449A1 (en) 2017-09-21
EP3429577A1 (en) 2019-01-23
RU2018136108A (ru) 2020-04-15
KR102626973B1 (ko) 2024-01-22
WO2017160269A1 (en) 2017-09-21
JP2019508506A (ja) 2019-03-28
EP3429577B1 (en) 2021-12-29
DK3429577T3 (da) 2022-03-07
RU2018136108A3 (es) 2020-04-15
AU2016397562B2 (en) 2023-06-29
ES2906178T3 (es) 2022-04-13
US20190161467A1 (en) 2019-05-30
EP3429577A4 (en) 2019-11-06
US11155531B2 (en) 2021-10-26
CN109152757A (zh) 2019-01-04
CA3017449C (en) 2023-09-19
BR112018068456A2 (pt) 2019-01-22
AU2016397562A1 (en) 2018-09-27
JP6858837B2 (ja) 2021-04-14
EP4018997A1 (en) 2022-06-29
KR20180120769A (ko) 2018-11-06
RU2737377C2 (ru) 2020-11-27

Similar Documents

Publication Publication Date Title
CY1122603T1 (el) Γαμμα-δικετονες για τη θεραπευτικη αντιμετωπιση και την προληψη της γηρανσης του δερματος και των ρυτιδων
EP4421094A3 (en) Targeted therapeutic agents and uses thereof
PH12019501414A1 (en) Amino acid compositions and methods for the treatment of liver diseases
WO2019045248A3 (ko) 주름 개선 활성을 나타내는 펩타이드 및 이의 용도
MX389228B (es) Composiciones para tratar el cabello.
EP4553065A3 (en) Novel compounds for treating mitochondrial disease
WO2018068947A3 (de) Proteinhydrolysate
WO2016112208A3 (en) Topical applications of kv1.3 channel blocking peptides to treat skin inflammation
MX2018004616A (es) Cosmetica qie tiene bacterias probioticas.
EA201791537A1 (ru) Фармацевтическая композиция на основе наночастиц доцетаксела-альбумина, способ ее получения и ее применение
HK1220145A1 (zh) 胆漏治疗
HK1258675A1 (zh) 含有天然提取物的组合物以及它们在皮肤和毛发中的用途
MX2018011082A (es) Péptido o aminoácido n-lipoico, derivados y sus usos.
MX2022002635A (es) Anticuerpos anti proteina similar a angiopoyetina 4 y metodos de uso.
PH12017501003A1 (en) Aminoacid-based composition for fibroelastin recovery in dermal connective tissues
PH12017501070A1 (en) Peptides and their use in the treatment of skin
WO2019200314A3 (en) Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof
WO2015075062A3 (en) Method of treating hair
WO2018105941A3 (ko) 탈모방지 또는 발모촉진용 주사용 조성물
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
NZ732301A (en) Peptide compound, preparation method therefor, and application thereof
EP3925968A3 (en) Hsp70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
MX2018011121A (es) Prevención de la adherencia de tejido biológico.
WO2020117516A8 (en) Use of polycarboxylic acid compounds for the treatment of fibrous amino acid based substrates, especially hair
MX2022012371A (es) Peptido o aminoacido n-lipoico, derivados y sus usos.